Global Kidney/Renal Fibrosis Treatment Market Size, Status and Forecast 2019-2025

Published Date : 2019-08-12

Published By : Qy Research

Category : Pharma & Healthcare

No. of Pages : 91

Kidney/Renal fibrosis, defined as an aberrant wound healing process in response to chronic injury, is characterized by the progressive and persistent accumulation of extracellular matrix components (ECM) in the kidney, ultimately leading to renal failure.
In 2018, the global Kidney/Renal Fibrosis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Kidney/Renal Fibrosis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Kidney/Renal Fibrosis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Galectin Therapeutics
Merck & Co.
F. Hoffman-La Roche Ltd.
Pfizer Inc.
InterMune Inc.
ProMetic Life-Sciences Inc.
La Jolla Pharmaceutical Company
Genzyme Corporation
BioLine Rx Ltd

Market segment by Type, the product can be split into
Angiotensin II Receptor Blockers (ARBs)
Angiotensin Converting Enzyme (ACE) Inhibitors
Pirfenidone
Renin Inhibitors
Vasopeptidase Inhibitors

Market segment by Application, split into
Commercial/Private Hospitals
Public Health Hospitals
Clinics
Home Treatment

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Kidney/Renal Fibrosis Treatment status, future forecast, growth opportunity, key market and key players.
To present the Kidney/Renal Fibrosis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Kidney/Renal Fibrosis Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Kidney/Renal Fibrosis Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Angiotensin II Receptor Blockers (ARBs)
1.4.3 Angiotensin Converting Enzyme (ACE) Inhibitors
1.4.4 Pirfenidone
1.4.5 Renin Inhibitors
1.4.6 Vasopeptidase Inhibitors
1.5 Market by Application
1.5.1 Global Kidney/Renal Fibrosis Treatment Market Share by Application (2019-2025)
1.5.2 Commercial/Private Hospitals
1.5.3 Public Health Hospitals
1.5.4 Clinics
1.5.5 Home Treatment
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Kidney/Renal Fibrosis Treatment Market Size
2.2 Kidney/Renal Fibrosis Treatment Growth Trends by Regions
2.2.1 Kidney/Renal Fibrosis Treatment Market Size by Regions (2019-2025)
2.2.2 Kidney/Renal Fibrosis Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Kidney/Renal Fibrosis Treatment Market Size by by Players
3.1.1 Global Kidney/Renal Fibrosis Treatment Revenue by by Players (2014-2019)
3.1.2 Global Kidney/Renal Fibrosis Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Kidney/Renal Fibrosis Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Kidney/Renal Fibrosis Treatment Key Players Head office and Area Served
3.3 Key Players Kidney/Renal Fibrosis Treatment Product/Solution/Service
3.4 Date of Enter into Kidney/Renal Fibrosis Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Kidney/Renal Fibrosis Treatment Market Size by Type (2014-2019)
4.2 Global Kidney/Renal Fibrosis Treatment Market Size by Application (2014-2019)

5 North America
5.1 North America Kidney/Renal Fibrosis Treatment Market Size (2014-2019)
5.2 Kidney/Renal Fibrosis Treatment Key Players in North America
5.3 North America Kidney/Renal Fibrosis Treatment Market Size by Type
5.4 North America Kidney/Renal Fibrosis Treatment Market Size by Application

6 Europe
6.1 Europe Kidney/Renal Fibrosis Treatment Market Size (2014-2019)
6.2 Kidney/Renal Fibrosis Treatment Key Players in Europe
6.3 Europe Kidney/Renal Fibrosis Treatment Market Size by Type
6.4 Europe Kidney/Renal Fibrosis Treatment Market Size by Application

7 China
7.1 China Kidney/Renal Fibrosis Treatment Market Size (2014-2019)
7.2 Kidney/Renal Fibrosis Treatment Key Players in China
7.3 China Kidney/Renal Fibrosis Treatment Market Size by Type
7.4 China Kidney/Renal Fibrosis Treatment Market Size by Application

8 Japan
8.1 Japan Kidney/Renal Fibrosis Treatment Market Size (2014-2019)
8.2 Kidney/Renal Fibrosis Treatment Key Players in Japan
8.3 Japan Kidney/Renal Fibrosis Treatment Market Size by Type
8.4 Japan Kidney/Renal Fibrosis Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Kidney/Renal Fibrosis Treatment Market Size (2014-2019)
9.2 Kidney/Renal Fibrosis Treatment Key Players in Southeast Asia
9.3 Southeast Asia Kidney/Renal Fibrosis Treatment Market Size by Type
9.4 Southeast Asia Kidney/Renal Fibrosis Treatment Market Size by Application

10 India
10.1 India Kidney/Renal Fibrosis Treatment Market Size (2014-2019)
10.2 Kidney/Renal Fibrosis Treatment Key Players in India
10.3 India Kidney/Renal Fibrosis Treatment Market Size by Type
10.4 India Kidney/Renal Fibrosis Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Kidney/Renal Fibrosis Treatment Market Size (2014-2019)
11.2 Kidney/Renal Fibrosis Treatment Key Players in Central & South America
11.3 Central & South America Kidney/Renal Fibrosis Treatment Market Size by Type
11.4 Central & South America Kidney/Renal Fibrosis Treatment Market Size by Application

12 International Players Profiles
12.1 Galectin Therapeutics
12.1.1 Galectin Therapeutics Company Details
12.1.2 Company Description and Business Overview
12.1.3 Kidney/Renal Fibrosis Treatment Introduction
12.1.4 Galectin Therapeutics Revenue in Kidney/Renal Fibrosis Treatment Business (2014-2019))
12.1.5 Galectin Therapeutics Recent Development
12.2 Merck & Co.
12.2.1 Merck & Co. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Kidney/Renal Fibrosis Treatment Introduction
12.2.4 Merck & Co. Revenue in Kidney/Renal Fibrosis Treatment Business (2014-2019)
12.2.5 Merck & Co. Recent Development
12.3 F. Hoffman-La Roche Ltd.
12.3.1 F. Hoffman-La Roche Ltd. Company Details
12.3.2 Company Description and Business Overview
12.3.3 Kidney/Renal Fibrosis Treatment Introduction
12.3.4 F. Hoffman-La Roche Ltd. Revenue in Kidney/Renal Fibrosis Treatment Business (2014-2019)
12.3.5 F. Hoffman-La Roche Ltd. Recent Development
12.4 Pfizer Inc.
12.4.1 Pfizer Inc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Kidney/Renal Fibrosis Treatment Introduction
12.4.4 Pfizer Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2014-2019)
12.4.5 Pfizer Inc. Recent Development
12.5 InterMune Inc.
12.5.1 InterMune Inc. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Kidney/Renal Fibrosis Treatment Introduction
12.5.4 InterMune Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2014-2019)
12.5.5 InterMune Inc. Recent Development
12.6 ProMetic Life-Sciences Inc.
12.6.1 ProMetic Life-Sciences Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Kidney/Renal Fibrosis Treatment Introduction
12.6.4 ProMetic Life-Sciences Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2014-2019)
12.6.5 ProMetic Life-Sciences Inc. Recent Development
12.7 La Jolla Pharmaceutical Company
12.7.1 La Jolla Pharmaceutical Company Company Details
12.7.2 Company Description and Business Overview
12.7.3 Kidney/Renal Fibrosis Treatment Introduction
12.7.4 La Jolla Pharmaceutical Company Revenue in Kidney/Renal Fibrosis Treatment Business (2014-2019)
12.7.5 La Jolla Pharmaceutical Company Recent Development
12.8 Genzyme Corporation
12.8.1 Genzyme Corporation Company Details
12.8.2 Company Description and Business Overview
12.8.3 Kidney/Renal Fibrosis Treatment Introduction
12.8.4 Genzyme Corporation Revenue in Kidney/Renal Fibrosis Treatment Business (2014-2019)
12.8.5 Genzyme Corporation Recent Development
12.9 BioLine Rx Ltd
12.9.1 BioLine Rx Ltd Company Details
12.9.2 Company Description and Business Overview
12.9.3 Kidney/Renal Fibrosis Treatment Introduction
12.9.4 BioLine Rx Ltd Revenue in Kidney/Renal Fibrosis Treatment Business (2014-2019)
12.9.5 BioLine Rx Ltd Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details


List of Tables and Figures

Table Kidney/Renal Fibrosis Treatment Key Market Segments
Table Key Players Kidney/Renal Fibrosis Treatment Covered
Table Global Kidney/Renal Fibrosis Treatment Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Angiotensin II Receptor Blockers (ARBs) Figures
Table Key Players of Angiotensin II Receptor Blockers (ARBs)
Figuer Angiotensin Converting Enzyme (ACE) Inhibitors Figures
Table Key Players of Angiotensin Converting Enzyme (ACE) Inhibitors
Figuer Pirfenidone Figures
Table Key Players of Pirfenidone
Figuer Renin Inhibitors Figures
Table Key Players of Renin Inhibitors
Figuer Vasopeptidase Inhibitors Figures
Table Key Players of Vasopeptidase Inhibitors
Table Global Kidney/Renal Fibrosis Treatment Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Kidney/Renal Fibrosis Treatment Market Share by Application in 2018 & 2025
Figure Commercial/Private Hospitals Case Studies
Figure Public Health Hospitals Case Studies
Figure Clinics Case Studies
Figure Home Treatment Case Studies
Figure Kidney/Renal Fibrosis Treatment Report Years Considered
Figure Global Kidney/Renal Fibrosis Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Kidney/Renal Fibrosis Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Kidney/Renal Fibrosis Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Kidney/Renal Fibrosis Treatment Market Share by Regions 2014-2019
Figure Global Kidney/Renal Fibrosis Treatment Market Share by Regions 2014-2019
Figure Global Kidney/Renal Fibrosis Treatment Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Kidney/Renal Fibrosis Treatment Revenue by by Players (2014-2019) (Million US$)
Table Global Kidney/Renal Fibrosis Treatment Market Share by by Players (2014-2019)
Figure Global Kidney/Renal Fibrosis Treatment Market Share by by Players in 2018
Table Global Kidney/Renal Fibrosis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Kidney/Renal Fibrosis Treatment Product/Solution/Service
Table Date of Enter into Kidney/Renal Fibrosis Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Kidney/Renal Fibrosis Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Kidney/Renal Fibrosis Treatment Market Size Share by Type (2014-2019)
Figure Global Kidney/Renal Fibrosis Treatment Market Size Market Share by Type (2014-2019)
Table Global Kidney/Renal Fibrosis Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Kidney/Renal Fibrosis Treatment Market Size Share by Application (2014-2019)
Figure Global Kidney/Renal Fibrosis Treatment Market Size Market Share by Application (2014-2019)
Figure Global Kidney/Renal Fibrosis Treatment Revenue Market Share by Application in 2018
Figure North America Kidney/Renal Fibrosis Treatment Market Size 2014-2019 (Million US$)
Table North America Key Players Kidney/Renal Fibrosis Treatment Revenue (2018-2019) (Million US$)
Table North America Key Players Kidney/Renal Fibrosis Treatment Market Share (2018-2019)
Table North America Kidney/Renal Fibrosis Treatment Market Size by Type 2014-2019 (Million US$)
Table North America Kidney/Renal Fibrosis Treatment Market Share by Type 2014-2019
Table North America Kidney/Renal Fibrosis Treatment Market Size by Application 2014-2019 (Million US$)
Table North America Kidney/Renal Fibrosis Treatment Market Share by Application 2014-2019
Figure Europe Kidney/Renal Fibrosis Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Kidney/Renal Fibrosis Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Kidney/Renal Fibrosis Treatment Market Share (2018-2019)
Table Europe Kidney/Renal Fibrosis Treatment Market Size by Type 2014-2019 (Million US$)
Table Europe Kidney/Renal Fibrosis Treatment Market Share by Type 2014-2019
Table Europe Kidney/Renal Fibrosis Treatment Market Size by Application 2014-2019 (Million US$)
Table Europe Kidney/Renal Fibrosis Treatment Market Share by Application 2014-2019
Figure China Kidney/Renal Fibrosis Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Kidney/Renal Fibrosis Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Kidney/Renal Fibrosis Treatment Market Share (2018-2019)
Table China Kidney/Renal Fibrosis Treatment Market Size by Type 2014-2019 (Million US$)
Table China Kidney/Renal Fibrosis Treatment Market Share by Type 2014-2019
Table China Kidney/Renal Fibrosis Treatment Market Size by Application 2014-2019 (Million US$)
Table China Kidney/Renal Fibrosis Treatment Market Share by Application 2014-2019
Figure Japan Kidney/Renal Fibrosis Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Kidney/Renal Fibrosis Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Kidney/Renal Fibrosis Treatment Market Share (2018-2019)
Table Japan Kidney/Renal Fibrosis Treatment Market Size by Type 2014-2019 (Million US$)
Table Japan Kidney/Renal Fibrosis Treatment Market Share by Type 2014-2019
Table Japan Kidney/Renal Fibrosis Treatment Market Size by Application 2014-2019 (Million US$)
Table Japan Kidney/Renal Fibrosis Treatment Market Share by Application 2014-2019
Figure Southeast Asia Kidney/Renal Fibrosis Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Kidney/Renal Fibrosis Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Kidney/Renal Fibrosis Treatment Market Share (2018-2019)
Table Southeast Asia Kidney/Renal Fibrosis Treatment Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Kidney/Renal Fibrosis Treatment Market Share by Type 2014-2019
Table Southeast Asia Kidney/Renal Fibrosis Treatment Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Kidney/Renal Fibrosis Treatment Market Share by Application 2014-2019
Figure India Kidney/Renal Fibrosis Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Kidney/Renal Fibrosis Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Kidney/Renal Fibrosis Treatment Market Share (2018-2019)
Table India Kidney/Renal Fibrosis Treatment Market Size by Type 2014-2019 (Million US$)
Table India Kidney/Renal Fibrosis Treatment Market Share by Type 2014-2019
Table India Kidney/Renal Fibrosis Treatment Market Size by Application 2014-2019 (Million US$)
Table India Kidney/Renal Fibrosis Treatment Market Share by Application 2014-2019
Figure Central & South America Kidney/Renal Fibrosis Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Kidney/Renal Fibrosis Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Kidney/Renal Fibrosis Treatment Market Share (2018-2019)
Table Central & South America Kidney/Renal Fibrosis Treatment Market Size by Type 2014-2019 (Million US$)
Table Central & South America Kidney/Renal Fibrosis Treatment Market Share by Type 2014-2019
Table Central & South America Kidney/Renal Fibrosis Treatment Market Size by Application 2014-2019 (Million US$)
Table Central & South America Kidney/Renal Fibrosis Treatment Market Share by Application 2014-2019
Table Galectin Therapeutics Company Details
Table Galectin Therapeutics Revenue in Kidney/Renal Fibrosis Treatment Business 2014-2019 (Million US$)
Figure Galectin Therapeutics Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2014-2019)
Table Galectin Therapeutics Recent Development
Table Merck & Co. Company Details
Table Merck & Co. Revenue in Kidney/Renal Fibrosis Treatment Business 2014-2019 (Million US$)
Figure Merck & Co. Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2014-2019)
Table Merck & Co. Recent Development
Table F. Hoffman-La Roche Ltd. Company Details
Table F. Hoffman-La Roche Ltd. Revenue in Kidney/Renal Fibrosis Treatment Business 2014-2019 (Million US$)
Figure F. Hoffman-La Roche Ltd. Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2014-2019)
Table F. Hoffman-La Roche Ltd. Recent Development
Table Pfizer Inc. Company Details
Table Pfizer Inc. Revenue in Kidney/Renal Fibrosis Treatment Business 2014-2019 (Million US$)
Figure Pfizer Inc. Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2014-2019)
Table Pfizer Inc. Recent Development
Table InterMune Inc. Company Details
Table InterMune Inc. Revenue in Kidney/Renal Fibrosis Treatment Business 2014-2019 (Million US$)
Figure InterMune Inc. Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2014-2019)
Table InterMune Inc. Recent Development
Table ProMetic Life-Sciences Inc. Company Details
Table ProMetic Life-Sciences Inc. Revenue in Kidney/Renal Fibrosis Treatment Business 2014-2019 (Million US$)
Figure ProMetic Life-Sciences Inc. Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2014-2019)
Table ProMetic Life-Sciences Inc. Recent Development
Table La Jolla Pharmaceutical Company Company Details
Table La Jolla Pharmaceutical Company Revenue in Kidney/Renal Fibrosis Treatment Business 2014-2019 (Million US$)
Figure La Jolla Pharmaceutical Company Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2014-2019)
Table La Jolla Pharmaceutical Company Recent Development
Table Genzyme Corporation Company Details
Table Genzyme Corporation Revenue in Kidney/Renal Fibrosis Treatment Business 2014-2019 (Million US$)
Figure Genzyme Corporation Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2014-2019)
Table Genzyme Corporation Recent Development
Table BioLine Rx Ltd Company Details
Table BioLine Rx Ltd Revenue in Kidney/Renal Fibrosis Treatment Business 2014-2019 (Million US$)
Figure BioLine Rx Ltd Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2014-2019)
Table BioLine Rx Ltd Recent Development
Table Global Kidney/Renal Fibrosis Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Kidney/Renal Fibrosis Treatment Market Size Share by Regions (2019-2025)
Figure Global Kidney/Renal Fibrosis Treatment Market Size Share by Regions in 2025
Figure North America Kidney/Renal Fibrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Kidney/Renal Fibrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Kidney/Renal Fibrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Kidney/Renal Fibrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Kidney/Renal Fibrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Kidney/Renal Fibrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Kidney/Renal Fibrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Kidney/Renal Fibrosis Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Kidney/Renal Fibrosis Treatment Market Size by Product (2019-2025)
Figure Global Kidney/Renal Fibrosis Treatment Market Size by Product in 2025
Table Global Kidney/Renal Fibrosis Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Kidney/Renal Fibrosis Treatment Market Size by Application (2019-2025)
Figure Global Kidney/Renal Fibrosis Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Kidney/Renal Fibrosis Treatment  Research Assistance Research Assistance

We will be happy to help you find what you need. Please write to us:

+1-888-213-4282

sales@researchreportcenter.com